Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Nakaraang pagsara
NT$880.00
Sakop ng araw
NT$869.00 - NT$889.00
Sakop ng taon
NT$436.00 - NT$1,020.00
Market cap
136.53B TWD
Average na Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (TWD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 9.36M | -37.19% |
Gastos sa pagpapatakbo | 135.35M | 10.35% |
Net na kita | -56.14M | 52.55% |
Net profit margin | -599.57 | 24.46% |
Kita sa bawat share | -0.30 | — |
EBITDA | -122.99M | -15.21% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (TWD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 9.67B | 160.51% |
Kabuuang asset | 9.77B | 155.34% |
Kabuuang sagutin | 73.70M | -13.86% |
Kabuuang equity | 9.70B | — |
Natitirang share | 153.83M | — |
Presyo para makapag-book | 13.96 | — |
Return on assets | -3.28% | — |
Return on capital | -3.30% | — |
Cash Flow
Net change in cash
| (TWD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -56.14M | 52.55% |
Cash mula sa mga operasyon | -42.00M | 65.87% |
Cash mula sa pag-invest | -2.10B | -2,797.15% |
Cash mula sa financing | 18.12M | -99.40% |
Net change in cash | -2.13B | -170.96% |
Malayang cash flow | -64.80M | — |
Tungkol
Itinatag
2012
Website
